The EMT transcription factor TWIST1 mediates resistance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

被引：1
|
作者：
Yochum, Zachary A.
Wang, Hailun
Cades, Jessica A.
Khetarpal, Susheel
Huang, Eric H.
Tran, Phouc T.
Burns, Timothy F.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4118
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
    Zachary A. Yochum
    Jessica Cades
    Hailun Wang
    Suman Chatterjee
    Brian W. Simons
    James P. O’Brien
    Susheel K. Khetarpal
    Ghali Lemtiri-Chlieh
    Kayla V. Myers
    Eric H.-B. Huang
    Charles M. Rudin
    Phuoc T. Tran
    Timothy F. Burns
    [J]. Oncogene, 2019, 38 : 656 - 670
  • [2] Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
    Yochum, Zachary A.
    Cades, Jessica
    Wang, Hailun
    Chatterjee, Suman
    Simons, Brian W.
    O'Brien, James P.
    Khetarpal, Susheel K.
    Lemtiri-Chlieh, Ghali
    Myers, Kayla V.
    Huang, Eric H. -B.
    Rudin, Charles M.
    Tran, Phuoc T.
    Burns, Timothy F.
    [J]. ONCOGENE, 2019, 38 (05) : 656 - 670
  • [3] Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR-mutant non-small cell lung cancer
    Qin, Qiong
    Li, Xiaoqing
    Liang, Xingmei
    Zeng, Lili
    Wang, Jing
    Sun, Linlin
    Zhong, Diansheng
    [J]. THORACIC CANCER, 2021, 12 (11) : 1708 - 1715
  • [4] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [5] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
    Santoni-Rugiu, Eric
    Melchior, Linea C.
    Urbanska, Edyta M.
    Jakobsen, Jan N.
    de Stricker, Karin
    Grauslund, Morten
    Sorensen, Jens B.
    [J]. CANCERS, 2019, 11 (07)
  • [7] Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Padole, Atul
    Chen, Tianqi
    Peterson, P. Gabriel
    Piotrowska, Zofia
    Sequist, Lecia, V
    [J]. CANCERS, 2019, 11 (09)
  • [8] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Otsuka, Kyoko
    Hata, Akito
    Takeshita, Jumpei
    Okuda, Chiyuki
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Katakami, Nobuyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 835 - 841
  • [9] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Kyoko Otsuka
    Akito Hata
    Jumpei Takeshita
    Chiyuki Okuda
    Reiko Kaji
    Katsuhiro Masago
    Shiro Fujita
    Nobuyuki Katakami
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
  • [10] Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach
    Jassem, Jacek
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S387 - S390
12345